Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-09-16
2008-09-16
Morris, Patricia L (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S201000
Reexamination Certificate
active
11064896
ABSTRACT:
The invention relates to compounds of formula:and to solvates and/or hydrates thereof, with affinity for and selectivity towards the V1breceptors or both the V1band V1areceptors of arginine-vasopressin.The invention also relates to a process for preparing them, to the intermediate compounds of formula (II) which are useful for preparing them, to pharmaceutical compositions containing them and to their use for preparing medicinal products.
REFERENCES:
patent: 5338755 (1994-08-01), Wagnon et al.
patent: 5594023 (1997-01-01), Wagnon et al.
patent: 5773612 (1998-06-01), Wagnon et al.
patent: WO 95 18105 (1995-07-01), None
Roux Richard
Serradeil-le Gal Claudine
Wagnon Jean
Bolcsak James W.
Morris Patricia L
Sanofi-Aventis
LandOfFree
1,3-dihydro-2H-indol-2-one derivatives, process for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,3-dihydro-2H-indol-2-one derivatives, process for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,3-dihydro-2H-indol-2-one derivatives, process for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3955938